143 related articles for article (PubMed ID: 25902723)
1. Erdheim-Chester disease presenting as periodontal disease: Experience of treatment with cladribine, interferon-a, local radiotherapy and anakinra.
Blomstrand L; Thor A; Hagberg H
Acta Oncol; 2016; 55(2):248-50. PubMed ID: 25902723
[No Abstract] [Full Text] [Related]
2. [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].
Adam Z; Petrášová H; Řehák Z; Koukalová R; Krejčí M; Pour L; Vetešníková E; Čermák A; Ševčíková S; Szturz P; Král Z; Mayer J
Vnitr Lek; 2016; 62(10):820-832. PubMed ID: 27900869
[TBL] [Abstract][Full Text] [Related]
3. Erdheim-Chester disease.
Brychtová M; Vlachová M; Gregorová J; Krejčí M; Adam Z; Ševčíková S
Klin Onkol; 2021; 34(6):434-439. PubMed ID: 34911328
[TBL] [Abstract][Full Text] [Related]
4. Erdheim-Chester disease with cardiac involvement successfully treated with anakinra.
Killu AM; Liang JJ; Jaffe AS
Int J Cardiol; 2013 Sep; 167(5):e115-7. PubMed ID: 23659884
[No Abstract] [Full Text] [Related]
5. Erdheim-Chester Disease: a comprehensive review of the literature.
Mazor RD; Manevich-Mazor M; Shoenfeld Y
Orphanet J Rare Dis; 2013 Sep; 8():137. PubMed ID: 24011030
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pediatric Erdheim-Chester disease with interleukin-1-targeting drugs.
Tran TA; Pariente D; Lecron JC; Delwail A; Taoufik Y; Meinzer U
Arthritis Rheum; 2011 Dec; 63(12):4031-2. PubMed ID: 21898344
[No Abstract] [Full Text] [Related]
7. [PET-CT documented complete remission of Erdheim-Chester disease, lasting more than 4 years from treatment initiation with cladribine].
Adam Z; Řehák Z; Koukalová R; Bortlíček Z; Krejčí M; Pour L; Szturz P; Prášek J; Nebeský T; Adamová Z; Král Z; Mayer J
Vnitr Lek; 2014; 60(5-6):499, 501-11. PubMed ID: 24974755
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist protein.
Courcoul A; Vignot E; Chapurlat R
Joint Bone Spine; 2014 Mar; 81(2):175-7. PubMed ID: 23953221
[TBL] [Abstract][Full Text] [Related]
9. Anakinra-responsive lichen planus in a woman with Erdheim-Chester disease: a therapeutic enigma.
Cohen PR; Kurzrock R
Dermatol Online J; 2014 Jan; 20(1):21241. PubMed ID: 24456945
[TBL] [Abstract][Full Text] [Related]
10. Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease.
Cohen-Aubart F; Maksud P; Saadoun D; Drier A; Charlotte F; Cluzel P; Amoura Z; Haroche J
Blood; 2016 Mar; 127(11):1509-12. PubMed ID: 26847247
[No Abstract] [Full Text] [Related]
11. Interferon-alpha in cardiac Erdheim-Chester disease.
Monti L; Haroche J; Sciarra A; Balzarini L; Fiamengo B; Amoura Z; Graziani G
J Am Coll Cardiol; 2011 Dec; 58(25):2695. PubMed ID: 22152958
[No Abstract] [Full Text] [Related]
12. [Erdheim-Chester disease].
Haroche J; Cohen-Aubart F; Arnaud L; Hervier B; Charlotte F; Drier A; Gorochov G; Grenier PA; Cluzel P; Maksud P; Emile JF; Amoura Z
Rev Med Interne; 2014 Nov; 35(11):715-22. PubMed ID: 24878295
[TBL] [Abstract][Full Text] [Related]
13. [Successful treatment of Erdheim-Chester disease by 2-chlorodeoxyadenosine-based chemotherapy. Two case studies and a literature review].
Adam Z; Koukalová R; Sprláková A; Rehák Z; Cervinek L; Szturz P; Krejcí M; Pour L; Zahradová L; Moulis M; Prásek J; Chaloupka R; Hájek R; Mayer J
Vnitr Lek; 2011 Jun; 57(6):576-89. PubMed ID: 21751544
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of Erdheim-Chester disease with combination of interleukin-1-targeting drugs and high-dose glucocorticoids.
Darstein F; Kirschey S; Heckl S; Rahman F; Schwarting A; Schuchmann M; Galle PR; Zimmermann T
Intern Med J; 2014 Jan; 44(1):90-2. PubMed ID: 24450524
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Erdheim-Chester disease with cladribine: a rational approach.
Myra C; Sloper L; Tighe PJ; McIntosh RS; Stevens SE; Gregson RH; Sokal M; Haynes AP; Powell RJ
Br J Ophthalmol; 2004 Jun; 88(6):844-7. PubMed ID: 15148234
[No Abstract] [Full Text] [Related]
16. Favorable radiological outcome of skeletal Erdheim-Chester disease involvement with anakinra.
Aubert O; Aouba A; Deshayes S; Georgin-Lavialle S; Rieu P; Hermine O
Joint Bone Spine; 2013 Mar; 80(2):206-7. PubMed ID: 22999905
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy and interferon-alpha treatment of Erdheim-Chester disease.
Jeon IS; Lee SS; Lee MK
Pediatr Blood Cancer; 2010 Oct; 55(4):745-7. PubMed ID: 20589628
[TBL] [Abstract][Full Text] [Related]
18. Erdheim-Chester disease in childhood: a challenging diagnosis and treatment.
Tran TA; Fabre M; Pariente D; Craiu I; Haroche J; Charlotte F; Eid P; Durrbach A; Taoufik Y; Kone-Paut I
J Pediatr Hematol Oncol; 2009 Oct; 31(10):782-6. PubMed ID: 19755920
[TBL] [Abstract][Full Text] [Related]
19. [Erdheim-Chester disease: report of a case with retroperitoneal involvement treated with interferon alpha-2a].
Gil Ortega M; López Lozano E; Girela Baena E; Navarro Martinez N
Med Clin (Barc); 2013 Sep; 141(5):227-8. PubMed ID: 23452672
[No Abstract] [Full Text] [Related]
20. The "hairy kidney" sign.
Triffo WJ; Dyer RB
Abdom Radiol (NY); 2017 Mar; 42(3):979-980. PubMed ID: 27841012
[No Abstract] [Full Text] [Related]
[Next] [New Search]
